TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03860038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma in Relapse
Refractory Multiple Myeloma

Interventions

DRUG: TJ202 and Dexamethasone

Sponsor

TJ Biopharma Co., Ltd.